Results 101 to 110 of about 163,674 (312)

Treatment of Coronary Perforation in a Bifurcation: Two‐Stent Strategies With Fenestrated Covered Stents

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Coronary perforations are a dreaded complication for any interventional cardiologist. The treatment of this complication is exceptionally difficult when it occurs in a coronary bifurcation. While a conservative approach or a balloon occlusion might be sufficient in some cases, additional treatment is sometimes necessary.
Jakob U. Lindner, Janine Pöss, Holger Thiele, Dmitry S. Sulimov   +3 more
wiley   +1 more source

Prevalence of Conventional Risk Factors in ST Segment Elevation Myocardial Infarction Patients in Shahid Gangalal National Heart Centre, Nepal

Journal of Nepal Medical Association, 2014
Introduction: Smoking, diabetes mellitus, hypertension, and dyslipidemia are labelled as conventional risk factors for coronary artery disease. Prevalence of these risk factors varies across populations. This study aimed to assess the prevalence of these
Chandra Mani Adhikari, Dipanker Prajapati, Bibek Baniya, Sudhir Regmi, Amrit Bogati, Suman Thapaliya   +5 more
doaj   +1 more source

Platelet glycoprotein IIb/IIIa receptor blockers in clinical practice [PDF]

, 2001
I n this thesis, platelet glycoprotein (GP) IIb/IIIa receptor blockers are discussed for use in patients with acute coronary syndromes without persistent ST-segment elevation but also for use in patients with overt myocardial infarction.
Ronner, E. (Eelko)
core   +2 more sources

Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Coronary slow flow (SF) and no‐reflow (NR) are clinically significant complications of percutaneous coronary intervention (PCI), particularly in ST‐segment elevation myocardial infarction (STEMI) and saphenous vein graft (SVG) interventions. Angiographically defined as impaired myocardial perfusion despite restored epicardial patency, SF/NR ...
Bharat Khialani, Eran Sim, George Touma, Sarah Fairley, Cuneyt Ada, Bernard Wong   +5 more
wiley   +1 more source

Timing of coronary artery bypass grafting after myocardial infarction influences late survivalCentral MessagePerspective

JTCVS Open
Objectives: The role of timing of coronary artery bypass grafting after acute myocardial infarction on early and late outcomes remains uncertain. Methods: We reviewed 1631 consecutive adult patients who underwent isolated coronary artery bypass grafting ...
Sri Harsha Patlolla, MBBS, MS, Juan A. Crestanello, MD, Hartzell V. Schaff, MD, Alberto Pochettino, MD, John M. Stulak, MD, Richard C. Daly, MD, Kevin L. Greason, MD, Joseph A. Dearani, MD, Nishant Saran, MBBS   +8 more
doaj   +1 more source

Pneumonitis and pulmonary haemorrhage after acute myocardial infarction [PDF]

, 2015
A 55-year-old man presented with acute ST-elevation myocardial infarction. He received rescue angioplasty with one drug eluting stent. He developed marked breathlessness and haemoptysis two days later.
Millar, Colin GM, Noman, Awsan, Parasuraman, Sathish K, Teo, Alison IC   +3 more
core   +1 more source

Untargeted Metabolomics Identifies N‐Lactoyl‐Amino Acids as Dose‐Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Metformin is the most widely prescribed antidiabetic drug, yet adherence remains difficult to objectively assess. Using untargeted metabolomics and lipidomics, we analyzed plasma from 637 patients with type 2 diabetes (T2D) with confirmed metformin use and 143 nondiabetic controls, annotating 614 metabolites.
Tomas Cajka, Jiri Hricko, Lucie Rudl Kulhava, Michaela Paucova, Michaela Novakova, Veronika Hola, Stanislava Rakusanova, Oliver Fiehn, Vojtech Skop, Ivana Lankova, Iva Miskova, Terezie Pelikanova, Martin Haluzik   +12 more
wiley   +1 more source

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

Trials, 2009
Background Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction.
Gu Youlan L, Fokkema Marieke L, Kampinga Marthe A, de Smet Bart JGL, Tan Eng S, van den Heuvel Ad FM, Zijlstra Felix   +6 more
doaj   +1 more source

Gambaran Hematologi Pada Pasien Sindrom Koroner Akut Yang Dirawat Di Blu Rsup Prof. Dr. R.d. Kandou Manado Tahun 2010 [PDF]

, 2013
: Acute coronary syndrome (ACS) is a series of clinical disorders caused by acute ischemic heart disease, including angina unstable, non-ST elevation myocardial infarction, and ST-elevation myocardial infarction.
Ramadhani, B. Y. (Bagus), Rotty, L. W. (Linda), Wantania, F. (Frans)   +2 more
core  

ST2 in Stable and Unstable Ischemic Heart Diseases [PDF]

, 2015
Circulating suppression of tumorigenicity 2 (ST2) predicts cardiovascular outcomes and mortality in ischemic heart disease (IHD). ST2 does not correlate with traditional risk indicators as closely as N-terminal pro–brain natriuretic peptide (NT-proBNP ...
DI SOMMA, Salvatore, Mueller, T., Richards, Am   +2 more
core   +1 more source